Further, to determine whether RASEF downregulation accounted for the anti-proliferative effect of NCOA2 depletion, we assessed breast cancer cell growth after RASEF knockdown in MTS cell proliferation (Figure 5D) and colony formation (Figure 5E) assays. Here, RASEF is linked to breast carcinoma.